| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
BioNexus Gene Lab Corp
13D
BGLC · 090628306
|
11.5% |
8/14/2026
Event 8/13/2026
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.